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A SWEET solution to rice blight
Two studies offer a powerful strategy for combating bacterial blight in rice.
Rajeev K. Varshney, Ian D. Godwin, Trilochan Mohapatra, Jonathan D. G. Jones and Susan R. McCouch
Bacterial blight is an important disease of rice that is particularly destructive in Southeast Asia and sub-Saharan 
Africa, exacerbated by the heavy rains of the 
monsoon seasons. Estimated crop loss due 
to bacterial blight may be as high as 75%, 
with millions of hectares of rice affected 
annually. In this issue, an international team 
of researchers describes the use of CRISPR 
editing to generate rice plants that are 
broadly resistant to the main pathogen that 
causes rice blight, Xanthomonas oryzae pv. 
oryzae (Xoo)1. To enhance the durability and 
management of resistance, the team has also 
developed a kit to trace the disease, and its 
virulence and resistance alleles2.
The most sustainable, cost-effective and 
safe approach to controlling rice blight is 
the use of genetically resistant plants. A 
total of 43 different genes conferring host 
resistance to bacterial blight have been 
identified in rice so far, and a subset has 
been characterized3. Through genomics-
assisted breeding, more than ten resistant 
rice varieties have been developed. Several 
of these varieties4, which rely on resistance 
genes Xa4, xa5, xa13, Xa21, Xa33 and 
Xa38, have been released for commercial 
cultivation across the globe.
In the biological arms race that is plant-
pathogen interactions, plant resistance is 
often overcome by the emergence of potent 
pathogen virulence mechanisms. The 
Xoo pathogen produces specific effector 
molecules that promote the host’s provision 
of the sugar required for bacterial growth. 
These transcription activator–like effectors 
(TALEs) bind to effector-binding elements 
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Fig. 1 | Overview of the development of genome-edited lines for key SWEET genes and features of a diagnostic kit for combating bacterial blight rice. a, 
Development of genome-edited lines for three (SWEET 11, SWEET13 and SWEET14) genes in the genetic background of Kitaake, IR64 and Ciherang-Sub1. 
Edited EBEs for these genes were also stacked in the genetic background of Kitaake. Phenotyping of the lines showed full resistance to bacterial blight with the 
current set of Xoo strains. Therefore, after ensuring that they do not contain off-target mutations and confirming acceptable agronomic performance in mega 
environments, these lines can be deployed in rice-growing countries that allow genome-edited products. b, Components of a diagnostic kit for combating 
bacterial blight in rice. The kit includes SWEETup, a qRT-PCR primer set for detection of SWEET gene induction by Xoo strain; SWEETacc, GUS tester lines in the 
background of Kitaake for the detection of SWEET protein accumulation by Xoo strains; SWEETko, knockout tester lines in the background of Kitaake for the 
detection of specific SWEET gene dependences; SWEETpR, tester lines in the background of Kitaake to study whether EBE mutations cause Xoo resistance; 
and SWEETR, genome edited rice lines in the background of IR64 and Ciherang-Sub1 containing multiple SWEET promoter variants. The kit also contains 
SWEETpDB, a SWEET promoter database for the identification of TALE targets in different rice lines, and a web-based SWEET PathoTracer for geographical 
information system–based prediction of optimal resistance gene deployment. This kit can be used to analyze pathogen populations in the field in a given 
geographic region and then to identify suitable resistant lines from the kit. These lines can be used as resistant donors, and desirable resistant lines can be 
developed through molecular breeding approaches.
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(a 21-gene family in rice), which encode 
sugar transporters. Activation of target 
SWEET genes elevates sugar transport to 
where the pathogen needs it, enhancing 
its virulence and leading to disease 
susceptibility.
Oliva et al.1 undertook an extensive 
survey of Xoo TALE diversity in 33 Asian 
and 30 African isolates, sequencing 856 
distinct TALEs. They found more copies of 
TALEs in Asian isolates (18–21 per genome) 
than in African isolates (9 per genome). 
The high number of TALEs indicated that 
the challenge of creating a TALE-insensitive 
line was greater than previously realized. 
The authors rose to this challenge by 
using CRISPR-Cas9 to edit promoters of 
SWEET11, SWEET13 and SWEET14 at EBEs 
recognized by pathogen TALEs with the aim 
of recovering SWEET promoter alleles of all 
three genes with reduced TALE binding.
TALE nuclease–directed mutation of 
SWEET14 was reported earlier for the 
development of bacterial blight–resistant 
lines to specific Xoo strains5,6. However, 
at that time, relatively few Xoo strains had 
been assessed for TALE gene content. 
Recently, natural variation in the promoters 
of SWEET13 and SWEET14 discovered in 
the 3K rice genome sequences7 expanded 
the range of known variants conferring Xoo 
resistance8.
Oliva et al.1 chose to target specific EBE 
polymorphisms based on their sequence-
level characterization of TALEs in 63 Xoo 
strains from diverse areas, and the mutations 
they discovered in the EBEs in promoters 
of SWEET11, SWEET13 and SWEET14 in 
rice. First, they engineered a rapidly cycling 
japonica line, Kitaake. To facilitate breeding 
in South East Asian programs, they then 
generated the same edits in two mega indica 
rice varieties, IR64 and Ciherang-Sub1 
(Fig. 1a).
Twenty-one SWEET variants in the mega 
varieties showed high levels of resistance 
to tested Xoo strains of bacterial blight. 
Given that the SWEET genes have key roles 
in sugar transport and signaling in the 
developing plant, it was reassuring that no 
adverse effects on field performance, plant 
development or grain yield were observed. 
Furthermore, they applied a multiplexed 
genome editing approach to systematically 
interfere with SWEET gene induction at all 
known major TALE EBEs, and engineered 
Kitaake lines resistant to all currently known 
Xoo strains (Fig. 1a). This strategy builds on 
a deep understanding of the mechanisms 
governing host–pathogen interaction, 
and we anticipate that it will be applied to 
develop broad-spectrum disease resistance 
in other crops.
In the companion paper, Eom et al.2 
developed a diagnostic kit, called SWEETR 
v 1.0, for analyzing field strains of the rice 
bacterial blight pathogen, for predicting 
SWEET genes targeted by Xoo TAL effectors 
and for customizing the introduction of 
resistant variants into elite rice varieties 
to manage the disease. The toolset 
includes a SWEET promotor database 
(SWEETpDB); SWEETup qRT-PCR primers; 
three SWEETacc rice tester lines; single and 
combined SWEETko knock-out mutants; 
SWEETpR tester lines in the R-gene-free 
Kitaake background; a web-based SWEET 
PathoTracer decision tool; and 32 transgene 
free EBE-edited lines of the indica mega 
varieties, IR64 and Ciherang-Sub1. The kit 
is designed to facilitate systematic genomic 
analysis of Xoo populations, evaluate 
the efficacy of resistant tester lines, and 
accelerate development and deployment of 
bacterial blight–resistant rice lines, which 
can be released alone or in multi-line 
combinations (Fig. 1b). A similar concept 
can be used to manage disease in other 
crops, like cotton and cassava, that show 
SWEET-based resistance to bacterial blight.
In our view, these two papers provide 
a compelling strategy for combating 
bacterial blight in rice. However, as noted 
by Oliva et al.1, whole-genome sequencing 
of genome-edited lines is required to 
identify possible off-target mutations, and 
field testing in different environments 
for bacterial blight and agronomic trait 
performance is needed before formal release 
and deployment.
Genome editing has now been used to 
generate useful traits in many crops—such 
as rice, maize, wheat, sugarcane, soybean, 
potato, sorghum, orange, cucumber, tomato, 
flax and cassava—targeting herbicide 
resistance, drought-stress tolerance, 
thermosensitive genic male sterility, disease 
resistance and altered product quality, 
with some in the process of release for 
commercial cultivation9. The stewardship 
of gene-edited lines in combination with an 
appropriate deployment strategy is essential 
to meet environmental health and safety 
standards. There remains a lack of clarity as 
to the non-GMO status of such germplasm 
in many countries worldwide10. We hope 
that legislation and public opinion will soon 
allow the benefits of this research to reach 
the farming community.
Furthermore, we note that the diagnostic 
kit for the development of blight-resistant 
rice, together with the genome-edited 
SWEET R-lines, will be useful in tracking 
the evolution of the pathogen and selecting 
suitable donors carrying desirable resistance 
genes that can be introduced into new 
varieties through genomic-assisted breeding 
approaches (Fig. 1). We are confident that 
these studies will be helpful for many other 
crops in which genome sequencing for large-
scale germplasm collections is underway, 
and a similar strategy can be used to develop 
genome-edited lines and kits to help manage 
both current and future diseases. ❐
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